from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3620c/esxW

LFCtreatmentdescriptionclass of inhibitor

-0.203

Amikacinug/mL Amikacintranslation

0.130

Cap5-10ug/mL Capreomycintranslation

-0.660

Rox10-50 ug/mL Roxithromycintranslation

0.173

SM2-5 ug/mL Streptomycintranslation

-0.603

Tet5-10 ug/mL Tetracyclinetranslation

-1.696

Rif0.2-5ug/mL Rifampicintranscription

-1.379

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.294

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.509

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.548

CPZ10-50 ug/mL Chlorpromazinerespiration

0.168

Clofazimine10-13 ug/mL Clofaziminerespiration

0.178

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.521

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.008

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.118

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.228

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.829

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.382

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.168

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.112

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.110

KCN5-20 ug/mL Potassium cyaniderespiration

0.102

NaN30.2-2 mM Sodium aziderespiration

0.511

Nigericin50 uM Nigericinrespiration

-1.038

TRC10-150 ug/mL Triclosanrespiration

-0.044

TRZ10-25 ug/mL Thioridazinerespiration

-2.051

Valinomycin0.5-10 uM Valinomycinrespiration

0.282

ZnSO42 mM ZnSO4respiration

-0.295

menadione6-10 ug/mL Menadionerespiration

1.091

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.564

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.858

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.400

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.546

NRP_1Non-replicating persistence stage 1dosRassociated

0.904

Amp0.2mg/mL AmpicillincellWall

0.261

Cephalexin20-100 ug/mL CephalexincellWall

0.191

Cerulenin0.32-5 ug/mL CerulenincellWall

0.832

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.917

EMB10-20 ug/mL EthambutolcellWall

0.658

Eta12-40 ug/mL EthionamidecellWall

0.460

INH0.2-0.4 ug/mL IsoniazidcellWall

0.350

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.405

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.210

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.418

BZA0.12 mg/mL BenzamidearomaticAmides

-0.956

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.169

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.273

H2O24 mM hydrogen peroxideDNAdamaging

0.504

Levo10 ug/mL LevofloxacinDNAdamaging

0.613

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.855

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.409

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.527

UVUV-irradiationDNAdamaging

-0.828

ARP41-4 ug/mL Antitubercular compound ARP4?

0.820

Antimycin12.5-50 ug/mL Antimycin A?

0.195

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.586

PA_110-50 ug/mL Antitubercular compound PA-1?

0.649

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.444

PA8240.2-2 ug/mL PA-824?

-0.024

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.039

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.074

Verapamil50 uM Verapamil?

0.248

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.074

methoxatin10-20 ug/mL Methoxatin?